Cargando…
Tamoxifen side effects: pharmacogenetic and clinical approach in Mexican mestizos
BACKGROUND: Tamoxifen metabolism is translated into four genetic phenotypes (GP): genetic poor metabolizer (gPM); genetic intermediate metabolizer (gIM); genetic normal metabolizer (gNM); and genetic ultra-rapid metabolizer (gUM). Although CYP2D6 is involved in tamoxifen biotransformation, its assoc...
Autores principales: | Rangel-Méndez, Jorge-Aarón, Rubi-Castellanos, Rodrigo, Sánchez-Cruz, Juan-Francisco, Moo-Puc, Rosa Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798170/ https://www.ncbi.nlm.nih.gov/pubmed/35116730 http://dx.doi.org/10.21037/tcr.2018.12.27 |
Ejemplares similares
-
Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population
por: Rodríguez-Rivera, Nidia Samara, et al.
Publicado: (2017) -
Arsenic exposure and risk of preeclampsia in a Mexican mestizo population
por: Sandoval-Carrillo, Ada, et al.
Publicado: (2016) -
Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico
por: Gonzalez-Covarrubias, Vanessa, et al.
Publicado: (2019) -
Genetic Epidemiology of Type 2 Diabetes in Mexican Mestizos
por: García-Chapa, Eiralí Guadalupe, et al.
Publicado: (2017) -
Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population
por: Cazarín-Santos, Benny Giovanni, et al.
Publicado: (2022)